Science Spotlight: HTT variant increases risk for fibromyalgia
BioCentury’s roundup of translational innovations also includes engineering bacteria for cancer
An international consortium conducted the largest genetic study of fibromyalgia to date, identifying 26 genome-wide significant risk loci and providing evidence that the disorder is a CNS condition rather than a peripheral or autoimmune one.
The meta-analysis pooled 11 cohorts spanning 54,629 cases of fibromyalgia and over 2.5 million controls. The strongest signal was a coding variant in HTT, the gene that causes Huntington's disease, conferring about a 9% increase in fibromyalgia risk. The variant is statistically independent from the repeat expansion that causes Huntington's itself...